In MCD DLBCL, TLR9/BCR coactivation drives the formation of the internalized MyD88-TLR9-BCR (My-T-BCR) complex, which hyperactivates mTOR from late endosomes (21). The gene discussed is MYD88; the disease is diffuse large B-cell lymphoma.